Epidemiological profile of deaths from breast cancer and covid-19
DOI:
https://doi.org/10.33448/rsd-v10i8.17269Keywords:
Breast Neoplasms; Mortality; Health Profile; COVID-19.Abstract
Cancer patients are at higher risk for the development of COVID-19 disease in its most severe form. Objective: to analyze mortality from breast cancer associated with COVID-19 in Brazilian women. Methodology: This is a quantitative study. Data were collected on the Open Data SUS website, from January to August 2020. Descriptive statistics were used for data analysis. Results: breast cancer associated with COVID-19 caused 69 deaths in this period, the ages with the highest number of deaths were in the age ranges 45-49 (14.5%), 60-64 (14.5%) and 65-69 years (14.5%). Regarding race, (56.52%) were white, followed by brown (31.88%). Only (31.88%) had 8 years or more of education and (49.27%) were married. Regarding the underlying cause of death, he presented ICD B34.2 (Infection by Coronavirus of unspecified location) in greater numbers, with a frequency of 52 (75.36%) and ICD C50.9 (Malignant breast cancer, unspecified) had a frequency of 17 (24.64%). The city with the highest number of deaths from breast cancer associated with COVID-19, which reached 14 (20.29%) of cases, was Rio de Janeiro (RJ), followed by the city of São Bernardo do Campo (SP) with 5 (7.25 %). Conclusion: The increase in breast cancer mortality during the COVID-19 pandemic in Brazil can be attributed to the immunosuppression of these women and the COVID-19 coping measures, which reduced the demand for health care, access and availability of diagnostic services.
References
Azambuja, E., Trapani, D., Loibl, S., Delaloge, S., Senkus, E., et al. (2020). Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. ESMO Open. Doi: 10.1136/esmoopen-2020-000793.
Curigliano, G., Cardoso, M. J., Poortmans, P., Gentilini, O., Pravettoni, G., et al. (2020). Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. The Breast, 52 (8), 8-16. Doi: 10.1016 / j.breast.2020.04.006.
Dietz, J. R., Moran, M. S., Isakof, S. J., Kurtzman, S. H., Willey, S. C., et al. (2020) Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The Breast, 181, 487-497. Doi: 10.1007 / s10549-020-05644-z.
Elghazawy, H., Bakkach, J., Zaghloul, M. S., Abusanad, A., Hussein, M. M., Alorabi, M., et al. (2020) Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic. Future Oncol, 16 (31), 2217. Doi: 10.2217/fon-2020-0574.
Emami, A., Javanmardi, F., Pirbonyeh, N., Akbari, A. (2020). Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Archives of Academic Emergency Medicine, 8 (1): e35. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096724/pdf/aaem-8-e35.pdf17.
Guan, W. J., Liang, W. H., Zhao, Y., Liang, H. R., Chen, Z. S., et al. (2020). Comorbidity and its impact on 1590 patients with COVID-19 in China: a Nationwide analysis. European Respiratory Journal, 55 (5), 2000547. Doi: 10.1183 / 13993003.00547-2020.
Kuderer, N., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubistein, S. M., et al. (2020). Clinical impact of COVID-19 on patient with cancer (CCC19): a cohort study. The Lancet, 395 (10241), 1907-1918. Doi: 10.1016/S0140-6736(20)31187-9.
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., et al. (2020). Cancer patients in SARS-CoV-2 infection: a Nationwide analysis in China. The Lancet, 21 (3), 30096-6. Doi: 0.1016/S1470-2045(20)30096-6.
Luther, A., Agrawal A. (2020). A practical approach to the management of breast cancer in the COVID-19 era and beyond. Ecancer medical Science, 14: 1059. Doi: 10.3332 / ecancer.2020.1059.
Manoj, G. S., Kabeer, K. K., Jafferbhoy, S., Marla, S., Soumian, S., Misra, V., et al. (2020). Breast Cancer Management Guidelines During COVID-19 Pandemic. Indian J Surg, 2, 1-8. Doi:10.1007/s12262-020-02466-7.
Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, H., et al. (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. The Lancet Oncology, 21(8), 1023-1034. Doi: 10.1016 / S1470-2045 (20) 30388-0.
Ministério da Saúde (MS). Secretaria de Vigilância em Saúde. Orientações para o preenchimento da Declaração de Óbito no contexto da COVID-19. (2020). Retrieved september 22, 2020. From: http://docs.bvsalud.org/biblioref/2020/05/1096249/orienta-es-para-delcara-o-de-bito.pdf.
Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. (2019) Analysis of the epidemiological characteristics of new coronavirus pneumonia. Chinese Journal of Epidemiology ,41(2), 145-51. Doi: https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003.
Olabumuyi, A. A., Ali-Gombe, M., Biyi-Olutunde, O. A., Gbolahan, O., Iwuji, C. O., Joseph, A. O., et al. (2020). Oncology practice in the COVID-19 pandemic: a reporto f a Nigerian expert panel discussion (oncology care in Nigeria during the COVID-19 pandemic). Pan Afr Med, 6(36), 153. Doi: 10.11604/pamj.2020.36.153.23662.
Organização Mundial da Saúde (OMS). Coronavirus disease (COVID-19) pandemic. Numbers at a glance.(2020) Retrieved september 22, 2020. From: ttps://www.who.int/emergencies/diseases/novel-coronavirus 2019?gclid=CjwKCAjw4rf6BRAvEiwAn2Q76jTwPLGB5ONXSdFZenPy0fEvG1m6V9arDDmCvjpQrxR0gtb1MZelkhoCmUsQAvD_BwE.
Pardoa, R., Algara, M., Montero-Fernández, A. M., Sanz, X., Vernet, M., et al. (2020) Diagnosis and locoregional treatment of patients with breast cancer during the COVID-19 pandemic. Revista de Senología Y Patología Mamaria, 33(2): 61-67. Doi: https://doi.org/10.1016/j.senol.2020.04.002
Salako, O., Okunade, K., Allsop, M., Habeebu, M., Toye, M., et al. (2020). Upheaval in cancer care during the COVID-19 outbreak. Ecancer medical science, 14(97). Doi: https://doi.org/10.3332/ecancer.2020.ed97.
Sociedade Brasileira de Oncologia Clínica (SBOC). Posicionamento SBOC. (2020).Retrieved september 22, 2020. From: https://sboc.org.br/images/Infogr%C3%A1fico_-_corona_v6.pdf.
Thuler, L. C. S., Melo, A. C. (2020). Sars-CoV-2/COVID-19 em pacientes com câncer. Revista Brasileira de Cancerologia, 66(2): e-00970. Doi: 10.32635/2176-9745.RBC.2020v66n2.970.
Chan JJ, Sim Y, Ow SGW, Lim JSJ, Kusumawidjaja G, Zhuang Q, Wong RX, Wong FY, Tan VKM, Tan TJ. (2020). The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience. Endocr Relat Cancer, 27(9), 307-327. Doi: 10.1530/ERC-20-0157. PMID: 32544879.Colocar espaço entre uma referência e outra.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Kely Paviani Stevanato; Amanda de Carvalho Dutra; Lander dos Santos; Igor Rosckovisk; Helena Fiats Ribeiro; Maria Dalva de Barros Carvalho; Raíssa Bocchi Pedroso; Sandra Marisa Pelloso
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.